AbbVie announced that its board of directors has unanimously elected chief executive officer (CEO) Robert A. Michael to assume the additional position of chairman, effective July 1, 2025. He will ...

AbbVie named its chief executive, Robert Michael, to succeed Richard Gonzalez as chairman of the biopharmaceutical company, effective July 1. AbbVie on Friday said Gonzalez, who has been chairman ...

Former AbbVie CEO Richard Gonzalez sold his Hidden Hills home for $21.7 million in the pharma executive’s latest real estate move this year. The closing had been expected after the six-bed ...

AbbVie Inc. has a 1 year low of $135.85 and a 1 year high of $193.91. Get AbbVie alerts: AbbVie (NYSE:ABBV – Get Free Report) last released its earnings results on Thursday, July 25th.

On August 5, 2024, Richard Gonzalez, Executive Chairman of the Board of AbbVie Inc (NYSE:ABBV), sold 66,500 shares of the company. The transaction was documented in a recent SEC Filing. Following this ...

As previously announced, Michael assumed the role on July 1. Robert A. Michael has assumed the role of CEO at AbbVie. 1 He has replaced Richard A. Gonzalez, who stepped down from the role after ...

AbbVie CEO Richard Gonzalez is the latest heavy hitter to buy in Boca Raton. The pharma boss dropped $14.3 million on a waterfront mansion, following a string of eight-figure deals in the city.

Robert A. Michael will become CEO of AbbVie starting on July 1, 2024. The current CEO, Richard A. Gonzalez, will step down on that same date, according to a press release. 1 According to the company, ...

AbbVie Inc.’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday, and will be replaced by the company’s current president and chief operating officer, Robert Michael.

AbbVie Inc.’s Chief Executive Officer Richard A. Gonzalez will retire after a colorful tenure that included the multibillion takeover of Botox-maker Allergan as he raced to wean the company off ...

AbbVie said longtime executive Robert Michael will become the company's new CEO, replacing Richard Gonzalez. Michael, who is AbbVie's president and chief operating officer, will become the ...